XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.
XFOREST Therapeutics has raised $6.1M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
XFOREST Therapeutics's investors include Takeda, ANRI, Miyako Capital, KSP, NEDO.
XFOREST Therapeutics is headquartered in Kyoto, Japan.
XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.
XFOREST Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"XFOREST Therapeutics — Funding & Investors." VCBacked, January 24, 2025, https://www.vcbacked.co/company/xforest-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). XFOREST Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/xforest-therapeutics
{{cite web |title=XFOREST Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xforest-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated